抑郁症药物进展（Advances in antidepressant drugs）.doc

抑郁症药物进展（Advances in antidepressant drugs） Drug therapy for depression Xinxiang Medical University, Hu Maolin Abstract: Depression (depression) belongs to affective disorders (mood, disor, ders) is a syndrome with significant and persistent low mood as the main feature of the high incidence rate, high recurrence rate and high rate of Dutch act has caused great harm to society. WHO (WHO) predicts that by 2020, depression will be ranked second in the global burden of disease. Depression is becoming a serious global problem. How to treat it has become a key issue. This review will review the development of antidepressants and look into the future. Key words: depression, antidepressant, drug therapy Objective: depression and mania belong to mood disorders, and affective disorders. WHO statistics, there are 340 million patients with depression worldwide, as well as 1~2 million suicidal tendencies, so depression has been listed as one of the key treatment and prevention of mental health in various countries. After a long and extensive exploration, it is believed that one of the factors contributing to depression is the abnormality of certain substances in the brain of the patient, such as norepinephrine (NE), serotonin (5-HT), Dobaamine (DA), or the abnormalities of its receptor (5-). By changing the concentration and delivery of this substance, the mood of the patient can be improved. This opens up a way for antidepressants to treat depression. In this paper, a wide range of relevant monographs and articles at home and abroad since 2000 have been summarized and summarized. text With the quickening pace of peoples life, mental pressure gradually increases, and depression has become a common disease and a high incidence of disease in modern society. WHO2005 statistics, the prevalence of depression, accounting for about 11% of the total population of the world, has become the worlds fourth major diseases, by 2020, may be the second most serious disease only after heart disea